Literature DB >> 27132483

Altered circadian clock gene expression in patients with schizophrenia.

Anne-Sofie Johansson1, Björn Owe-Larsson2, Jerker Hetta2, Gabriella B Lundkvist3.   

Abstract

Impaired circadian rhythmicity has been reported in several psychiatric disorders. Schizophrenia is commonly associated with aberrant sleep-wake cycles and insomnia. It is not known if schizophrenia is associated with disturbances in molecular rhythmicity. We cultured fibroblasts from skin samples obtained from patients with chronic schizophrenia and from healthy controls, respectively, and analyzed the circadian expression during 48h of the clock genes CLOCK, BMAL1, PER1, PER2, CRY1, CRY2, REV-ERBα and DBP. In fibroblasts obtained from patients with chronic schizophrenia, we found a loss of rhythmic expression of CRY1 and PER2 compared to cells from healthy controls. We also estimated the sleep quality in these patients and found that most of them suffered from poor sleep in comparison with the healthy controls. In another patient sample, we analyzed mononuclear blood cells from patients with schizophrenia experiencing their first episode of psychosis, and found decreased expression of CLOCK, PER2 and CRY1 compared to blood cells from healthy controls. These novel findings show disturbances in the molecular clock in schizophrenia and have important implications in our understanding of the aberrant rhythms reported in this disease.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biological clock; Circadian rhythm; Human; Molecular clock; Psychiatric disorder; Schizophrenia; Sleep

Mesh:

Substances:

Year:  2016        PMID: 27132483     DOI: 10.1016/j.schres.2016.04.029

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  27 in total

1.  Insomnia and suicidal ideation in nonaffective psychosis.

Authors:  Brian J Miller; Carmen B Parker; Mark H Rapaport; Peter F Buckley; William V McCall
Journal:  Sleep       Date:  2019-02-01       Impact factor: 5.849

2.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

3.  A web-based adapted physical activity program (e-APA) versus health education program (e-HE) in patients with schizophrenia and healthy volunteers: study protocol for a randomized controlled trial (PEPSY V@Si).

Authors:  Maxime Tréhout; Elise Leroux; Lucile Bigot; Solenne Jego; Pascal Leconte; Emmanuel Reboursière; Rémy Morello; Pierre-Alexandre Chapon; Aline Herbinet; Gaëlle Quarck; Sonia Dollfus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-05-26       Impact factor: 5.270

4.  Impact of adult attention deficit hyperactivity disorder and medication status on sleep/wake behavior and molecular circadian rhythms.

Authors:  A N Coogan; M Schenk; D Palm; A Uzoni; J Grube; A H Tsang; I Kolbe; N M McGowan; R Wandschneider; M Colla; H Oster; J Thome; F Faltraco
Journal:  Neuropsychopharmacology       Date:  2019-02-06       Impact factor: 7.853

Review 5.  Circadian integration of inflammation and glucocorticoid actions: Implications for the cochlea.

Authors:  Heela Sarlus; Jacopo Maria Fontana; Evangelia Tserga; Inna Meltser; Christopher R Cederroth; Barbara Canlon
Journal:  Hear Res       Date:  2019-03-15       Impact factor: 3.208

6.  Sex-specific hippocampal 5-hydroxymethylcytosine is disrupted in response to acute stress.

Authors:  Ligia A Papale; Sisi Li; Andy Madrid; Qi Zhang; Li Chen; Pankaj Chopra; Peng Jin; Sündüz Keleş; Reid S Alisch
Journal:  Neurobiol Dis       Date:  2016-08-26       Impact factor: 5.996

7.  Altered circadian activity and sleep/wake rhythms in the stable tubule only polypeptide (STOP) null mouse model of schizophrenia.

Authors:  Samuel Deurveilher; Kristin Robin Ko; Brock St C Saumure; George S Robertson; Benjamin Rusak; Kazue Semba
Journal:  Sleep       Date:  2021-04-09       Impact factor: 5.849

Review 8.  Sleep Abnormalities in Schizophrenia: State of the Art and Next Steps.

Authors:  Fabio Ferrarelli
Journal:  Am J Psychiatry       Date:  2021-03-17       Impact factor: 18.112

9.  Norepinephrine influences the circadian clock in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder.

Authors:  Denise Palm; Adriana Uzoni; Frederick Simon; Oliver Tucha; Johannes Thome; Frank Faltraco
Journal:  J Neural Transm (Vienna)       Date:  2021-07-18       Impact factor: 3.850

10.  Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder.

Authors:  Frank Faltraco; Denise Palm; Adriana Uzoni; Frederick Simon; Oliver Tucha; Johannes Thome
Journal:  J Neural Transm (Vienna)       Date:  2021-07-17       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.